These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 37422194)

  • 1. Updated Indications for Immune Effector Cell Therapy: 2023 Guidelines from the American Society for Transplantation and Cellular Therapy.
    Kanate AS; Majhail N; DeFilipp Z; Dhakal B; Dholaria B; Hamilton B; Herrera AF; Inamoto Y; Jain T; Perales MA; Carpenter PA; Hamadani M
    Transplant Cell Ther; 2023 Oct; 29(10):594-597. PubMed ID: 37422194
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Indications for Hematopoietic Cell Transplantation and Immune Effector Cell Therapy: Guidelines from the American Society for Transplantation and Cellular Therapy.
    Kanate AS; Majhail NS; Savani BN; Bredeson C; Champlin RE; Crawford S; Giralt SA; LeMaistre CF; Marks DI; Omel JL; Orchard PJ; Palmer J; Saber W; Veys PA; Carpenter PA; Hamadani M
    Biol Blood Marrow Transplant; 2020 Jul; 26(7):1247-1256. PubMed ID: 32165328
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Paving the Road for Chimeric Antigen Receptor T Cells: American Society for Transplantation and Cellular Therapy 80/20 Task Force Consensus on Challenges and Solutions to Improving Efficiency of Clinical Center Certification and Maintenance of Operations for Commercially Approved Immune Effector Cell Therapies.
    Nikiforow S; Frigault MJ; Frey NV; Gardner RA; Komanduri KV; Perales MA; Kebriaei P; Warkentin PI; Pasquini M; Aho JL; Levine BL; Heslop HE; Hlucky TL; Habucky K; Gharibo M; Jagasia M; Locke FL
    Transplant Cell Ther; 2023 Apr; 29(4):228-239. PubMed ID: 36709800
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Indications for Autologous and Allogeneic Hematopoietic Cell Transplantation: Guidelines from the American Society for Blood and Marrow Transplantation.
    Majhail NS; Farnia SH; Carpenter PA; Champlin RE; Crawford S; Marks DI; Omel JL; Orchard PJ; Palmer J; Saber W; Savani BN; Veys PA; Bredeson CN; Giralt SA; LeMaistre CF
    Biol Blood Marrow Transplant; 2015 Nov; 21(11):1863-1869. PubMed ID: 26256941
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessing Medicaid Coverage for Hematopoietic Cell Transplantation and Chimeric Antigen Receptor T Cell Therapy: A Project from the American Society for Transplantation and Cellular Therapy and the National Marrow Donor Program ACCESS Initiative.
    Auletta JJ; Khera N; DeMartino P; Kelkar AH; Yusuf RA; Davies SM; Knutson J; Beaver E; Maloney A; Majhail NS
    Transplant Cell Ther; 2023 Nov; 29(11):713-720. PubMed ID: 37579920
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical Practice Recommendations for Hematopoietic Cell Transplantation and Cellular Therapies in Follicular Lymphoma: A Collaborative Effort on Behalf of the American Society for Transplantation and Cellular Therapy and the European Society for Blood and Marrow Transplantation.
    Iqbal M; Kumar A; Dreger P; Chavez J; Sauter CS; Sureda AM; Bachanova V; Maziarz RT; Dreyling M; Smith SM; Jacobson C; Glass B; Casulo C; Oluwole OO; Montoto S; Advani R; Cohen J; Salles G; Hamad N; Kuruvilla J; Kahl BS; Shadman M; Kanate AS; Budde LE; Kamdar M; Flowers C; Hamadani M; Kharfan-Dabaja MA
    Transplant Cell Ther; 2024 Sep; 30(9):832-843. PubMed ID: 38972511
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparing CAR T-cell toxicity grading systems: application of the ASTCT grading system and implications for management.
    Pennisi M; Jain T; Santomasso BD; Mead E; Wudhikarn K; Silverberg ML; Batlevi Y; Shouval R; Devlin SM; Batlevi C; Brentjens RJ; Dahi PB; Diamonte C; Giralt S; Halton EF; Maloy M; Palomba ML; Sanchez-Escamilla M; Sauter CS; Scordo M; Shah G; Park JH; Perales MA
    Blood Adv; 2020 Feb; 4(4):676-686. PubMed ID: 32084260
    [TBL] [Abstract][Full Text] [Related]  

  • 8. American Society for Transplantation and Cellular Therapy Guidelines for Fellowship Training in Hematopoietic Cell Transplantation and Immune Effector Cell Therapy.
    Jain T; Knight T; Alencar MC; Davis L; Rao K; Im A; Malone AK;
    Transplant Cell Ther; 2022 Mar; 28(3):125-133. PubMed ID: 34954294
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ASTCT Consensus Grading for Cytokine Release Syndrome and Neurologic Toxicity Associated with Immune Effector Cells.
    Lee DW; Santomasso BD; Locke FL; Ghobadi A; Turtle CJ; Brudno JN; Maus MV; Park JH; Mead E; Pavletic S; Go WY; Eldjerou L; Gardner RA; Frey N; Curran KJ; Peggs K; Pasquini M; DiPersio JF; van den Brink MRM; Komanduri KV; Grupp SA; Neelapu SS
    Biol Blood Marrow Transplant; 2019 Apr; 25(4):625-638. PubMed ID: 30592986
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is There Still a Role for Transplant for Patients with Mantle Cell Lymphoma (MCL) in the Era of CAR-T Cell Therapy?
    Beitinjaneh A; Kaufman A; Wang Y; Jain P; Srour SA; Wang M
    Curr Treat Options Oncol; 2022 Nov; 23(11):1614-1625. PubMed ID: 36227407
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ASTCT, CIBMTR, and EBMT clinical practice recommendations for transplant and cellular therapies in mantle cell lymphoma.
    Munshi PN; Hamadani M; Kumar A; Dreger P; Friedberg JW; Dreyling M; Kahl B; Jerkeman M; Kharfan-Dabaja MA; Locke FL; Shadman M; Hill BT; Ahmed S; Herrera AF; Sauter CS; Bachanova V; Ghosh N; Lunning M; Kenkre VP; Aljurf M; Wang M; Maddocks KJ; Leonard JP; Kamdar M; Phillips T; Cashen AF; Inwards DJ; Sureda A; Cohen JB; Smith SM; Carlo-Stella C; Savani B; Robinson SP; Fenske TS
    Bone Marrow Transplant; 2021 Dec; 56(12):2911-2921. PubMed ID: 34413469
    [TBL] [Abstract][Full Text] [Related]  

  • 12. American Society for Blood and Marrow Transplantation Pharmacy Special Interest Group Survey on Chimeric Antigen Receptor T Cell Therapy Administrative, Logistic, and Toxicity Management Practices in the United States.
    Mahmoudjafari Z; Hawks KG; Hsieh AA; Plesca D; Gatwood KS; Culos KA
    Biol Blood Marrow Transplant; 2019 Jan; 25(1):26-33. PubMed ID: 30266675
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Grading of neurological toxicity in patients treated with tisagenlecleucel in the JULIET trial.
    Maziarz RT; Schuster SJ; Romanov VV; Rusch ES; Li J; Signorovitch JE; Maloney DG; Locke FL
    Blood Adv; 2020 Apr; 4(7):1440-1447. PubMed ID: 32271898
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of SARS-CoV-2 in Hematopoietic Stem Cell Transplantation and Chimeric Antigen Receptor T Cell Therapy Recipients.
    Mushtaq MU; Shahzad M; Chaudhary SG; Luder M; Ahmed N; Abdelhakim H; Bansal R; Balusu R; DeJarnette S; Divine C; Kribs R; Shune L; Singh AK; Ganguly S; Abhyankar SH; McGuirk JP
    Transplant Cell Ther; 2021 Sep; 27(9):796.e1-796.e7. PubMed ID: 34256172
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Voriconazole in Hematopoietic Stem Cell Transplantation and Cellular Therapies: Real-World Usage and Therapeutic Level Attainment at a Major Transplantation Center.
    Lindsay J; Krantz EM; Morris J; Sweet A; Tverdek F; Joshi A; Yeh R; Hill JA; Greenwood M; Chen SC; Kong DCM; Slavin M; Pergam SA; Liu C
    Transplant Cell Ther; 2022 Aug; 28(8):511.e1-511.e10. PubMed ID: 35623614
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The ASTCT-NMDP ACCESS Initiative: A Collaboration to Address and Sustain Equal Outcomes for All across the Hematopoietic Cell Transplantation and Cellular Therapy Ecosystem.
    Auletta JJ; Sandmaier BM; Jensen E; Majhail NS; Knutson J; Nemecek E; Ajayi-Hackworth F; Davies SM;
    Transplant Cell Ther; 2022 Dec; 28(12):802-809. PubMed ID: 36184058
    [TBL] [Abstract][Full Text] [Related]  

  • 17. American Society for Transplantation and Cellular Therapy Series, #6: Management of Invasive Candidiasis in Hematopoietic Cell Transplantation Recipients.
    Neofytos D; Steinbach WJ; Hanson K; Carpenter PA; Papanicolaou GA; Slavin MA
    Transplant Cell Ther; 2023 Apr; 29(4):222-227. PubMed ID: 36649748
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Practical aspects of CAR-T cell therapy.
    Jana M; Tomáš J; Michal K; Kateřina B; Juraj U; Ivo D; Zdeněk K; Roman H
    Klin Onkol; 2022; 35(1):44-54. PubMed ID: 35236081
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical Practice Recommendations on Indication and Timing of Hematopoietic Cell Transplantation in Mature T Cell and NK/T Cell Lymphomas: An International Collaborative Effort on Behalf of the Guidelines Committee of the American Society for Blood and Marrow Transplantation.
    Kharfan-Dabaja MA; Kumar A; Ayala E; Hamadani M; Reimer P; Gisselbrecht C; d'Amore F; Jantunen E; Ishida T; Bazarbachi A; Foss F; Advani R; Fenske TS; Lazarus HM; Friedberg JW; Aljurf M; Sokol L; Tobinai K; Tse E; Burns LJ; Chavez JC; Reddy NM; Suzuki R; Ahmed S; Nademanee A; Mohty M; Gopal AK; Fanale MA; Pro B; Moskowitz AJ; Sureda A; Perales MA; Carpenter PA; Savani BN
    Biol Blood Marrow Transplant; 2017 Nov; 23(11):1826-1838. PubMed ID: 28797780
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of Children with Malignancies for Blood and Marrow Transplantation: A Report from the ASTCT Committee on Practice Guidelines.
    Fraint E; Abdel-Azim H; Bhatt NS; Broglie L; Chattha A; Kohorst M; Ktena YP; Lee MA; Long S; Qayed M; Sharma A; Stefanski H; Vatsayan A; Wray L; Hamadani M; Carpenter PA
    Transplant Cell Ther; 2023 May; 29(5):293-301. PubMed ID: 36775202
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.